ArticleJournal of gynecologic oncology2026

Utility of iRECIST for evaluating treatment efficacy in patients receiving immune checkpoint inhibitors.

Genta Irie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.